Patents by Inventor Bilash Kuila

Bilash Kuila has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 6-Substituted Pyridazine Compounds as SMARCA2 and/or SMARCA4 Degraders
    Publication number: 20240018134
    Abstract: The present invention provides 6-substituted pyridazine compounds of formula (I) which are therapeutically useful as SMARCA2 and/or SMARCA4 degraders. These compounds are useful in the treatment and/or delaying progression of diseases or disorders dependent upon SMARCA2 and/or SMARCA4 in a subject. The present invention also provides preparation of the compounds and pharmaceutical compositions comprising at least one of the compounds of formula (I) or a pharmaceutically acceptable salt, or a stereoisomer or a tautomer or a prodrug thereof.
    Type: Application
    Filed: August 3, 2021
    Publication date: January 18, 2024
    Applicant: Aurigene Discovery Technologies Limited
    Inventors: Chandrasekhar Abbineni, Susanta Samajdar, Bilash Kuila, Subhendu Mukherjee, Suraj Tatyasaheb Gore
  • CO-CRYSTALS COMPRISING EPICATECHIN AND A CARBOXY-N-HETEROCYCLIC CO-CRYSTAL FORMER
    Publication number: 20210380535
    Abstract: The invention provides novel co-crystals of epicatechin with a carboxy-N-heterocyclic co-crystal former such as trigonelline or proline and their pharmaceutical compositions. Methods of preparing the co-crystals and methods of using them are also provided.
    Type: Application
    Filed: October 24, 2019
    Publication date: December 9, 2021
    Inventors: Sundeep DUGAR, Somdutta SEN, Bilash KUILA
  • Triazine compounds
    Patent number: 9630958
    Abstract: The present invention relates to novel triazine compounds of formula (1). The present invention also discloses compounds of formula I along with other pharmaceutical acceptable excipients and use of the compounds to modulate the PI3K/mTOR pathway.
    Type: Grant
    Filed: July 23, 2013
    Date of Patent: April 25, 2017
    Assignee: SPHAERA PHARMA PTE. LTD.
    Inventors: Sundeep Dugar, Dinesh Mahajan, Frank Hollinger Peter, Amit Sharma, Vinayak Tripathi, Bilash Kuila
  • NOVEL COMPOUNDS OF 11BETA-HYDROXY-STEROIDS FOR USE IN MITOCHONDRIA BIOGENESIS AND DISEASES ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTION OR DEPLETION
    Publication number: 20150376225
    Abstract: The present invention provides novel compounds of 11?-hydroxy steroids and compositions and their application as pharmaceuticals for preventing or reversing injury to mitochondria, for treating or preventing diseases relating to mitochondrial dysfunction or depletion, and for inducing regeneration or restructuring of mitochondria as a means of treating diseases relating to abnormalities in mitochondrial structure and function in a human or animal subject. Also disclosed herein are methods for diagnosing injury to mitochondria and for diagnosing the success or failure of therapeutics designed to treat, prevent, or reverse injury to or depletion of mitochondria.
    Type: Application
    Filed: January 23, 2014
    Publication date: December 31, 2015
    Inventors: Sundeep Dugar, Frederic George Schreiner, Dinesh Mahajan, Amit Sharma, Ishwar Rakesh Patil, Bilash Kuila
  • NOVEL TRIAZINE COMPOUNDS
    Publication number: 20150197515
    Abstract: The present invention relates to novel triazine compounds of formula (1). The present invention also discloses compounds of formula I along with other pharmaceutical acceptable excipients and use of the compounds to modulate the PI3K/mTOR pathway.
    Type: Application
    Filed: July 23, 2013
    Publication date: July 16, 2015
    Applicant: Sphaera Pharma Pte. Ltd.
    Inventors: Sundeep Dugar, Dinesh Mahajan, Frank Hollinger Peter, Amit Sharma, Vinayak Tripathi, Bilash Kuila